Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 431

1.

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS.

Int J Tuberc Lung Dis. 2012 Jan;16(1):90-7. doi: 10.5588/ijtld.11.0153.

2.

Extensively drug-resistant tuberculosis in the United States, 1993-2007.

Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP.

JAMA. 2008 Nov 12;300(18):2153-60. doi: 10.1001/jama.300.18.2153.

PMID:
19001626
3.

Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.

Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR.

PLoS One. 2010 Dec 29;5(12):e15735. doi: 10.1371/journal.pone.0015735.

4.

Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.

Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1228-33. doi: 10.5588/ijtld.12.0037. Epub 2012 Jun 28.

PMID:
22748131
5.

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH; Tugela Ferry Care and Research (TF CARES) Collaboration.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. doi: 10.1164/rccm.200907-0989OC. Epub 2009 Oct 15.

PMID:
19833824
6.

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.

PMID:
21943840
7.

Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

O'Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR.

Int J Tuberc Lung Dis. 2009 Jul;13(7):855-61.

8.

HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.

Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J.

J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.

PMID:
19886382
9.

Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence.

Liu TT, Wilson D, Dawood H, Cameron DW, Alvarez GG.

Clin Dev Immunol. 2012;2012:937013. doi: 10.1155/2012/937013. Epub 2012 Mar 19.

10.

Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa.

Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH.

PLoS One. 2012;7(3):e31786. doi: 10.1371/journal.pone.0031786. Epub 2012 Mar 6.

11.

Impact of drug-resistant tuberculosis on the survival of HIV-infected patients.

Sungkanuparph S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W.

Int J Tuberc Lung Dis. 2007 Mar;11(3):325-30.

PMID:
17352100
12.

Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.

Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G; Tugela Ferry Care and Research (TF CARES) Collaboration.

J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121. Review.

13.

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.

PMID:
20224066
14.

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C.

Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8.

15.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
16.

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.

O'Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr.

Emerg Infect Dis. 2013 Mar;19(3):416-24. doi: 10.3201/eid1903.120998.

17.

Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial.

Padayatchi N, Abdool Karim SS, Naidoo K, Grobler A, Friedland G.

Int J Tuberc Lung Dis. 2014 Feb;18(2):147-54. doi: 10.5588/ijtld.13.0627.

PMID:
24429305
18.

High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.

Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N.

Int J Tuberc Lung Dis. 2010 Apr;14(4):413-9.

19.

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR.

Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.

20.

Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.

Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, Woo PC.

PLoS One. 2011 Apr 29;6(4):e19399. doi: 10.1371/journal.pone.0019399.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk